Design Therapeutics, Inc. DSGN
12.12
(0.24)
(1.94%)
as of 25 Sep
- Market cap
- $809.3M
- P/E
- 0.0×
Follow DSGN
| Dec '17 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|
P/E ratio |
— | — | 0.00 | — | — | — | — | — |
P/S ratio |
— | — | 2,377.24 | — | — | — | — | — |
P/FCF ratio |
— | — | 0.00 | — | — | — | — | — |
P/Operating CF |
— | — | (188.91) | — | — | — | — | — |
P/B ratio |
— | — | 0.00 | — | — | — | — | — |
Price to Tangible BV |
— | — | 0.00 | — | — | — | — | — |
EV/Sales |
— | — | 2,217.54 | — | — | — | — | — |
EV/EBITDA |
— | — | 0.00 | — | — | — | — | — |
EV/Operating CF |
— | — | (57.81) | — | — | — | — | — |
EV/FCF |
— | — | (57.81) | — | — | — | — | — |
Quick Ratio |
— | 0.02 | 15.49 | 72.70 | 30.66 | 29.29 | 29.01 | 16.84 |
Current Ratio |
— | 0.02 | 15.55 | 72.96 | 31.10 | 29.58 | 29.31 | 17.14 |
Net Debt/EBITDA |
— | (0.23) | 4.30 | 10.73 | 4.82 | 3.37 | 3.61 | 2.68 |
Debt/Assets |
0.00% | 772.22% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Debt/Equity |
— | (0.19) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Asset Turnover |
— | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating CF/Net income |
— | 0.07 | 1.05 | 0.83 | 0.81 | 0.88 | 0.87 | 0.78 |
Capex/Depreciation |
— | — | 1.15 | (29.58) | 0.89 | 0.05 | 0.06 | 0.07 |
Interest Coverage |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| — | 27.37% | 110.72% | (19.16%) | (17.85%) | (22.10%) | (19.08%) | (30.70%) | |
| — | (4,548.89%) | (45.24%) | (16.64%) | (17.30%) | (21.20%) | (18.31%) | (29.18%) | |
ROIC |
— | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Return on Tangible Assets |
— | 56.22% | (24.37%) | (9.31%) | (19.40%) | (24.17%) | (20.58%) | (32.97%) |
Average Days of Receivables |
— | — | 0.00 | 0.00 | 0.00 | — | — | — |
Research and Development Expense of Revenue |
— | 0.00% | 2,681.42% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
— | 0.00% | 1,104.42% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
— | — | 199.12% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Graham Net Nets |
— | — | (0.02) | — | — | — | — | — |
Graham Number |
— | — | 2.91 | — | — | — | — | — |
Earnings Yield |
— | — | (1.54%) | — | — | — | — | — |
Free Cash Flow Yield |
— | — | (1.61%) | — | — | — | — | — |
Revenue per Share |
— | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating CF per Share |
— | 0.00 | (0.55) | (0.64) | (0.92) | (1.05) | (0.76) | (0.95) |
Capex per Share |
— | 0.00 | 0.00 | (0.03) | (0.02) | 0.00 | (0.01) | 0.00 |
Free Cash Flow per Share |
— | 0.00 | (0.55) | (0.67) | (0.94) | (1.05) | (0.77) | (0.95) |
Cash per Share |
— | 0.00 | 2.28 | 8.36 | 5.93 | 5.03 | 4.34 | 3.83 |
Shareholders Equity per Share |
— | (0.07) | (0.72) | 8.32 | 5.88 | 4.96 | 4.28 | 3.71 |
Interest Debt per Share |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
— | (0.07) | (0.72) | 8.32 | 5.88 | 4.96 | 4.28 | 3.71 |
Free Cash Flow |
— | (0.14) | (8.74) | (30.91) | (52.20) | (58.82) | (43.44) | (54.55) |
Working Capital |
— | (3.64) | 33.90 | 380.15 | 324.34 | 274.96 | 239.58 | 210.73 |
Capital Expenditures |
— | — | (0.08) | (1.54) | (0.88) | (0.26) | (0.34) | (0.19) |
Net Current Asset Value |
— | (3.64) | (11.60) | 377.01 | 321.29 | 272.63 | 238.04 | 210.08 |
EV/EBIT |
— | — | 0.00 | — | — | — | — | — |
Capex to Sales |
— | — | 0.34 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Profit Margin |
— | 0.00% | (3,663.72%) | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Price to Operating Income |
— | — | 0.00 | — | — | — | — | — |
| Other line items | ||||||||
Depreciation/Fixed assets |
— | — | (0.93) | 0.03 | (0.51) | (3.28) | (3.97) | (2.68) |
Cash ROIC |
— | 4.84% | (35.28%) | (4.03%) | (8.10%) | (10.77%) | (9.13%) | (12.80%) |
Accounts Receivable Turnover |
— | — | 3.77 | 0.00 | 0.00 | — | — | — |
Accounts Payable Turnover |
— | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Inventory Turnover |
— | — | 0.00 | 0.00 | 0.00 | — | — | — |
Average Days of Payables |
— | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Days of Inventory on Hand |
— | — | 0.00 | 0.00 | 0.00 | — | — | — |
Average Receivables |
— | — | 0.06 | 0.06 | 0.61 | — | — | — |
Average Payables |
— | — | 1.51 | 1.51 | 2.32 | 2.48 | 2.06 | 2.25 |
Average Assets |
— | 0.05 | 18.30 | 213.54 | 365.85 | 315.39 | 270.87 | 239.15 |
Average Common Equity |
— | (7.48) | (7.48) | 185.41 | 354.72 | 302.50 | 259.89 | 227.30 |
Columns are period end dates